Member Info for PurpleKenny

Don't you go pushing that SP up.

Great news but the elephant in the room is funding. SP won't rise because we're all scared of dilution.

Never mind P3 it would be great to know P1 is doing very well and cured.

Did I miss any news about Patient 2 and choosing Patient 3?

Listening to Cancer Research (CR UK) Advert yesterday were they want people to leave money in their will. Their budget was £692 million in 23/24 with £400 million going to research BUT £133 million was spent raising funds. I tried to see what drugs\treatments CR UK had contributed to and there really wasn't that many considering their annual budget.

It makes you realise how far HEMO has got on it's meagre budget and that HEMO is an opportunity for CR UK to invest and get a huge return.

Mind boggles. Positive news SP guess down.

Is this an AI generated article?

Could be these were 4p buys in January and they judge there will be no big announcements to move the SP up so they're moving money somewhere they think they can make a profit

I can only think the low odd number share sells are automated systems. Who has the time to sell one share at 6.15p

Lets hope Patient 1 is doing well. (well'er than before)

BeardedDragon hardly a blip on the SP, investors watching the for the next Raise. Maybe positive news about Patient 1 would move the dial.

I think live production at scale and portfolio members producing profit will demonstrate to market the value. Once a food producer is demonstrating competitive advantage then the market will sit up and listen.

So what is it? MrIndia big deal just round the corner or 6-7 years ?

If there was an opinion option of "Confused" I'd use it.

Vlad said something about 9 weeks of time with family. Then what?

17th March RNS 2nd patient had been selected. If they were as sick as we are lead to believe then its now 6 weeks later. Why the delay? This 6 weeks is presumably eating into funds.

Didn't "our" leather company disappear?

This share is a slow burn. There are rational arguments for the principals of the fund. Whether the companies in the fund come through is dependent on the competitive advantages of their technologies and processes. I'm hoping we got in early.

Strange no update on Patient 2. I thought their treatment was already being prepared. Surely with no adverse reaction from Patient 1 then Patient 2 would be a quick turn around. More info might prop up the SP.

Production Timeline: First gas production is now targeted for the **second quarter of 2025**, with the plant processing up to 550,000 cubic feet per day of raw gas.

I'd buy more if I was confident of no more sell outs. And Patient 2 must have been treated or a bit sicker by now.